title: The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.
authors.affiliation: Developmental Therapeutic Program, University of Colorado, 12801 E. 17th Avenue, Aurora, CO 80045, USA.
authors.forename: Sara A
authors.initials: SA
authors.lastname: Flanigan
authors.forename: Todd M
authors.initials: TM
authors.lastname: Pitts
authors.forename: S Gail
authors.initials: SG
authors.lastname: Eckhardt
authors.forename: John J
authors.initials: JJ
authors.lastname: Tentler
authors.forename: Aik Choon
authors.initials: AC
authors.lastname: Tan
authors.forename: Andrew
authors.initials: A
authors.lastname: Thorburn
authors.forename: Stephen
authors.initials: S
authors.lastname: Leong